Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet Rich Plasma for Nonobstructive Azoospermia
NCT05479474Recruiting
- Sponsor
- Stanford University
- Start
- Jan 2023
- Primary completion
- Dec 2026
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous platelet-rich plasma in nonobstructive azoospermia (NOA), sponsored by Stanford University. Primary endpoint: Presence of Sperm at 3 months. Started Jan 2023; status: recruiting.
02
Drugs
autologous platelet-rich plasma
03
Conditions
nonobstructive azoospermia (NOA)
Beyond the preview
Go deeper on NCT05479474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05479474.